Note: Ingredients listed on restricted chemical lists
EC/CAS
200-334-9/57-50-1
Name of the chemical
Sucrose, pure C12H22O11
Concentration
N/A
EC/CAS
9004-65-3
Name of the chemical
methylhydroxypropylcellulose
Concentration
N/A
EC/CAS
9004-64-2
Name of the chemical
hydroxypropylcellulose
Concentration
N/A
EC/CAS
200-066-2/25322-68-3
Name of the chemical
polyethyleneglycol
Concentration
N/A
EC/CAS
247-706-7/50-81-7
Name of the chemical
Ascorbic acid C6H8O6
Concentration
N/A
EC/CAS
209-150-3
Name of the chemical
Aluminium, zinc, magnesium and calcium stearates
Concentration
N/A
Opće informacije
Version
4
Datum revizije:
2025-11-01
Ime proizvoda:
Bazedoxifene - Conjugated Estrogen Tablets
Ime proizvoda:
Bazedoxifene - Conjugated Estrogen Tablets
a. Trgovačko ime
DUAVEE; DUAVIVE; APRELA
1.3 Sinonimi:
Bazedoxifene, Conjugated Estrogen Tablets
1.2 Kemijski naziv:
Nije utvrđeno
Sektor uporabe
Farmaceutski proizvod koji se koristi osteoporoza
Broj telefona službe za izvanredna stanja
1-800-424-9300, +1-703-527-3887
Icons in SDS
Podaci o tvrtki
Podaci o dobavljaču
Pfizer
e -mail
pfizer-MSDS@pfizer.com
GHS informacije
Signalna riječ
Opasnost
Hazard Codes
Hazard statements (CLP)
H317, H350, H360FD, H400, H410
Hazard statements
Code
Statements
H317
May cause an allergic skin reaction
